MAPK8 and non-Hodgkin lymphoma: Previous studies investigating the mechanism(s) of MAPK or AKT inhibitor-induced cell death in NHL and HL cell lines have demonstrated the induction of different death pathways involving both caspase-dependent and caspase-independent mechanisms26, ROS generation27, and JNK activation28.